Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person's chance ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

Eli Lilly (LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that ...

While the FDA had considered Lilly's (LLY) tirzepatide and Novo Nordisk's (NVO) semaglutide in short supply for months, Lilly's (LLY) products were taken off the shortage list in October.

As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take ... t be allowed to place liraglutide on its compounding list given that FDA-approved generics to Victoza are available.

The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...